Evidence map›Paper›PMID 30090205›Full record

ArticleAvicenna journal of medical biotechnology

Oghlniaz Jorjani, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhossein Dalimi, Hajar Ziaei-Hezarjaribi, Benyamin Talebi

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Avicenna journal of medical biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Advances inPathogens (Basel, Switzerland) · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Oghlniaz JorjaniLaboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Fatemeh GhaffarifarDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Zohreh SharifiResearch Center of Iranian Blood Transfusion Organizations, Tehran, Iran.
Abdolhossein DalimiDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hajar Ziaei-HezarjaribiDepartment of Parasitology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Benyamin TalebiPrivate Veterinary Physician, Gorgan, Iran.
Tarbiat Modares University · IRGolestan University · IRIranian Legal Medicine Organization · IRMazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeishmaniasis is caused by parasitic protozoa of the genus

methodsA DNA vaccine containing plasmids encoding the

resultsHumoral response and IFN-γ values were significantly higher than control groups after immunization with pcLACK, pcLACK+pcTSA+pCAGGS-IL12 and challenge with

conclusionThe survival time of the immunized mice with pcLACK, pcLACK+pcTSA+ pCAGGS-IL12 groups was higher than the control groups. Then, DNA vaccine of pcLACK appeared to be likely able to induce more protection against infection with

Indexed as

Cutaneous leishmaniasisDNA vaccineImmune response

Identifiers

PMID30090205
PMCPMC6064009
OpenAlexW2889193468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.